275 related articles for article (PubMed ID: 34782621)
1. Deficiency of autism risk factor ASH1L in prefrontal cortex induces epigenetic aberrations and seizures.
Qin L; Williams JB; Tan T; Liu T; Cao Q; Ma K; Yan Z
Nat Commun; 2021 Nov; 12(1):6589. PubMed ID: 34782621
[TBL] [Abstract][Full Text] [Related]
2. Loss of histone methyltransferase ASH1L in the developing mouse brain causes autistic-like behaviors.
Gao Y; Duque-Wilckens N; Aljazi MB; Wu Y; Moeser AJ; Mias GI; Robison AJ; He J
Commun Biol; 2021 Jun; 4(1):756. PubMed ID: 34145365
[TBL] [Abstract][Full Text] [Related]
3. ASH1L haploinsufficiency results in autistic-like phenotypes in mice and links Eph receptor gene to autism spectrum disorder.
Yan Y; Tian M; Li M; Zhou G; Chen Q; Xu M; Hu Y; Luo W; Guo X; Zhang C; Xie H; Wu QF; Xiong W; Liu S; Guan JS
Neuron; 2022 Apr; 110(7):1156-1172.e9. PubMed ID: 35081333
[TBL] [Abstract][Full Text] [Related]
4. Vorinostat, a histone deacetylase inhibitor, ameliorates the sociability and cognitive memory in an Ash1L-deletion-induced ASD/ID mouse model.
Gao Y; Aljazi MB; Wu Y; He J
Neurosci Lett; 2021 Nov; 764():136241. PubMed ID: 34509565
[TBL] [Abstract][Full Text] [Related]
5. ASH1L mutation caused seizures and intellectual disability in twin sisters.
Liu H; Liu DT; Lan S; Yang Y; Huang J; Huang J; Fang L
J Clin Neurosci; 2021 Sep; 91():69-74. PubMed ID: 34373061
[TBL] [Abstract][Full Text] [Related]
6. Chemogenetic Activation of Prefrontal Cortex Rescues Synaptic and Behavioral Deficits in a Mouse Model of 16p11.2 Deletion Syndrome.
Wang W; Rein B; Zhang F; Tan T; Zhong P; Qin L; Yan Z
J Neurosci; 2018 Jun; 38(26):5939-5948. PubMed ID: 29853627
[TBL] [Abstract][Full Text] [Related]
7. Counteracting epigenetic mechanisms regulate the structural development of neuronal circuitry in human neurons.
Cheon S; Culver AM; Bagnell AM; Ritchie FD; Vacharasin JM; McCord MM; Papendorp CM; Chukwurah E; Smith AJ; Cowen MH; Moreland TA; Ghate PS; Davis SW; Liu JS; Lizarraga SB
Mol Psychiatry; 2022 Apr; 27(4):2291-2303. PubMed ID: 35210569
[TBL] [Abstract][Full Text] [Related]
8. Impaired synaptic function and hyperexcitability of the pyramidal neurons in the prefrontal cortex of autism-associated Shank3 mutant dogs.
Zhu F; Shi Q; Jiang YH; Zhang YQ; Zhao H
Mol Autism; 2024 Jan; 15(1):9. PubMed ID: 38297387
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of autism-like social deficits by targeting histone methyltransferases EHMT1/2 in Shank3-deficient mice.
Wang ZJ; Zhong P; Ma K; Seo JS; Yang F; Hu Z; Zhang F; Lin L; Wang J; Liu T; Matas E; Greengard P; Yan Z
Mol Psychiatry; 2020 Oct; 25(10):2517-2533. PubMed ID: 30659288
[TBL] [Abstract][Full Text] [Related]
10. Autism spectrum disorder-like behavior caused by reduced excitatory synaptic transmission in pyramidal neurons of mouse prefrontal cortex.
Sacai H; Sakoori K; Konno K; Nagahama K; Suzuki H; Watanabe T; Watanabe M; Uesaka N; Kano M
Nat Commun; 2020 Oct; 11(1):5140. PubMed ID: 33046712
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic signatures of autism: trimethylated H3K4 landscapes in prefrontal neurons.
Shulha HP; Cheung I; Whittle C; Wang J; Virgil D; Lin CL; Guo Y; Lessard A; Akbarian S; Weng Z
Arch Gen Psychiatry; 2012 Mar; 69(3):314-24. PubMed ID: 22065254
[TBL] [Abstract][Full Text] [Related]
12. Expansion of the Genotypic and Phenotypic Spectrum of
Cordova I; Blesson A; Savatt JM; Sveden A; Mahida S; Hazlett H; Rooney Riggs E; Chopra M;
Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674358
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Control of Mesenchymal Stem Cell Fate Decision via Histone Methyltransferase Ash1l.
Yin B; Yu F; Wang C; Li B; Liu M; Ye L
Stem Cells; 2019 Jan; 37(1):115-127. PubMed ID: 30270478
[TBL] [Abstract][Full Text] [Related]
14. GABA
Wang X; Zhao Z; Guo J; Mei D; Duan Y; Zhang Y; Gou L
Brain Res Bull; 2023 Oct; 202():110755. PubMed ID: 37678443
[TBL] [Abstract][Full Text] [Related]
15. Change in serotonergic modulation contributes to the synaptic imbalance of neuronal circuit at the prefrontal cortex in the 15q11-13 duplication mouse model of autism.
Saitow F; Takumi T; Suzuki H
Neuropharmacology; 2020 Mar; 165():107931. PubMed ID: 31901366
[TBL] [Abstract][Full Text] [Related]
16. The histone methyltransferase ASH1L protects against bone loss by inhibiting osteoclastogenesis.
Zhao X; Lin S; Ren H; Sun S; Zheng L; Chen LF; Wang Z
Cell Death Differ; 2024 May; 31(5):605-617. PubMed ID: 38431690
[TBL] [Abstract][Full Text] [Related]
17. Upregulated NMDAR-mediated GABAergic transmission underlies autistic-like deficits in
Huang L; Wang J; Liang G; Gao Y; Jin SY; Hu J; Yang X; Lao J; Chen J; Luo ZC; Fan C; Xiong L; Zhu X; Gao TM; Zhong M; Yang X
Theranostics; 2021; 11(19):9296-9310. PubMed ID: 34646371
[TBL] [Abstract][Full Text] [Related]
18. The gut microbiota regulates autism-like behavior by mediating vitamin B
Li Y; Luo ZY; Hu YY; Bi YW; Yang JM; Zou WJ; Song YL; Li S; Shen T; Li SJ; Huang L; Zhou AJ; Gao TM; Li JM
Microbiome; 2020 Aug; 8(1):120. PubMed ID: 32819434
[TBL] [Abstract][Full Text] [Related]
19. Targeting histone demethylase LSD1 for treatment of deficits in autism mouse models.
Rapanelli M; Williams JB; Ma K; Yang F; Zhong P; Patel R; Kumar M; Qin L; Rein B; Wang ZJ; Kassim B; Javidfar B; Couto L; Akbarian S; Yan Z
Mol Psychiatry; 2022 Aug; 27(8):3355-3366. PubMed ID: 35296809
[TBL] [Abstract][Full Text] [Related]
20. Histone methyltransferase Ash1L mediates activity-dependent repression of neurexin-1α.
Zhu Τ; Liang C; Li D; Tian M; Liu S; Gao G; Guan JS
Sci Rep; 2016 May; 6():26597. PubMed ID: 27229316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
